<!doctype html>
<html>
<head>
<meta charset="UTF-8">
<meta name="apple-mobile-web-app-capable" content="yes">
<meta name="viewport" content="width=device-width initial-scale=1, user-scalable=no">
<meta name="apple-mobile-web-app-title" content="Janssen | REMICADE for IBD - Adult">
<title>Janssen | REMICADE for IBD - Adult</title>
<link rel="stylesheet" type="text/css" href="css/animate.min.css" />
<link rel="stylesheet" type="text/css" href="css/style.css" />
<style type="text/css">
	.content .feature { width: 105.2%; margin-left:-50px; height:380px; background-image:url('img/graph_8.png'); }
	.content .orange { margin-bottom:17px; }
	
	/* bottom menu */ 
	.footer-menu li > ul { left:-8.6em; }
	.footer-menu .goals > ul { width:256px; }
	.footer-menu .mucosal > ul,
	.footer-menu .steroid > ul { width:170px; }
	.footer-menu .steroid > ul {left: -4.8em; }
	.footer-menu .mucosal > ul {left: -4.5em; }
	
</style> 
</head>
<body>
	<section class="content-wrapper sides moderate">
    	<header>
        	<span class="remicade-logo right"></span> 
            <span class="section-label">Moderate<br />Severe UC</span>
        	<div class="btn-menu">
                <ul class="popup-menu">
                    <li class="btn-home"><i></i></li>
                    <li class="btn-ref circle"></li>
                    <li class="btn-mpi circle"></li>
                    <li class="btn-info circle"></li> 
                </ul>
            </div>
        </header>
    	<article class="inner-wrapper">
        	<div class="content">
            	<h2 class="g-line">Early mucosal healing with REMICADE predicts<br />
colectomy free survival<sup>1</sup></h2> 
				
				<p class="orange">Mucosal healing at week 4 or 10 after the first REMICADE infusion predicts colectomy-free<br />
survival over the long-term<sup>1</sup></p>
                <div class="feature"></div>
                <div class="footnote g-line">
                	 Adapted from Ferrante M <em>et al</em>, 2008.<sup>1</sup>
                </div>
            </div>
           
       		<!--footer menu -->
            <ul class="footer-menu">
                <li class="goals">
                	<ul>
                   		<li class="got">Goals of Tx</li>
                        <li class="pi">Patient indicators</li>
                        <li class="sa">Step-up algorithm</li>
                	</ul>
                    <span>Goals<br />of Tx</span>
                </li>
                <li class="rr">Response<br />&amp;&nbsp;Remission
                </li>
                <li class="steroid">
                	<ul>
                        <li class="ss">Steroid reduction</li>
                         <li class="sf">Steroid-free remission</li>
                	</ul>
                <span>Steroid<br />Sparing</span>
                </li>
                <li class="mucosal active">
                	<ul>
                        <li class="io">Improved outcomes</li>
                        <li class="cf selected">Colectomy-free survival</li>
                	</ul>
                    <span>Mucosal<br />Healing</span>
                </li>
                <li class="hosp mid">Hospitalisation</li>
                <li class="colectomy mid">Colectomy</li>
                <li class="surgery mid">Surgery</li>
                <li class="qol mid">QoL</li>
            </ul>
       
        </article>
        <div class="popup ref">
            <h3>Reference</h3>
            <ol>
                <li class="ref1">Ferrante M <em>et al</em>. J Crohns Colitis. 2008;2:219-225.</li>
            </ol>
        </div>
        
         <!--   Study design  -->
    	<div class="popup study-design">
    		<h3>Study design</h3>
         	Ferrante, 2008: Follow up study of 121 consecutive patients with ulcerative colitis uncontrolled by
conventional therapy, treated with either: a single dose of REMICADE 5 or 10 mg/kg or induction
schedule (5 or 10 mg/kg at weeks 0, 2 and 6). Short term response and mucosal healing (defined
as Mayo endoscopy subscore of 0 or 1 and only assessed in patients with Mayo subscore of &gt;2 at
inclusion) were assessed at wk 4 in patients who received a single infusion, wk 10 for those who
received the full induction course. Responders to REMICADE therapy (induction or single dose) could
receive either maintenance with REMICADE 5 or 10 mg/kg every 8 weeks (75% of patients) or
episodic therapy (25% of patients). Colectomy-free survival was assessed over a median follow-up
period of 33 (17-49.8) months.<sup>1</sup>
    	</div>
                
        <!-- popup main menu-->
        <aside class="main-menu animated">
        <span class="close circle"></span>
        	<ul class="level1">
            	<li class="cd">
                	<ul class="play">
                		<li class="home" data-slide="home">
                        	<span></span>
                        	<span></span>
                        	<span></span>
                        </li>
                		<li data-slide="cd">Crohn’s<br />disease</li>
                		<li data-slide="fist">Fistulising<br />Crohn’s disease</li>
                	</ul>
                </li>
                <li class="uc">
                	<ul class="play">
                    	<li data-slide="uc">Ulcerative<br />Colitis</li>
                		<li data-slide="ms">Moderate<br />Severe</li>
                		<li data-slide="as">Acute<br />Severe</li>
                	</ul>
                </li>
                <li class="common">
                	<ul class="play">
                		<li data-slide="st">Safety<br />& Tolerability</li>
                		<li data-slide="do">Dosing</li>
                		<li data-slide="ad">Adherence</li>
                		<li data-slide="pr">Preference</li>
                	</ul>
                </li>
            </ul>
        </aside>
        
    </section>
<script type="text/javascript" src="js/jquery-1.11.0.min.js"></script>
<script type="text/javascript" src="js/touchy.js"></script>
<script type="text/javascript" src="js/script.js"></script>
<script type="text/javascript">
	$( function(){
		
		//reference
		goToSlide('ref1', 'Ferrante2008');
	})
	
	
</script>
</body>
</html>
